HealthTech company Climedo has received EUR5 million in a seed financing round led by pan-European VC firm Nauta Capital. Westtech Ventures from Berlin and existing business angels including as Prof Dr Christian Wallwiener (WMC Healthcare) also participated in the round.  Climedo is a digital platform for electronic data capture in

Qumata, a specialist in tech solutions transforming the insurance industry ecosystem with a disruptive machine learning and artificial intelligence (ML/AI) underwriting solution, has extended its Series A round of funding to USD23 million. A number of the firms participating in this round are extending their initial involvement with Qumata, including

SpliceBio, a biotechnology company exploiting protein splicing to develop next generation gene therapies, has closed an oversubscribed EUR50 million series A financing co-led by UCB Ventures and existing shareholder Ysios Capital. New investors New Enterprise Associates (NEA), Gilde Healthcare, Novartis Venture Fund, and existing shareholder Asabys Partners also particpated.  The

TruArc Partners, a private equity firm focused on the middle-market, has invested in New Directions Aromatics (New Directions) in partnership with Founder and CEO, Alex Thomas. Based in Toronto, New Directions is a supplier of natural ingredients to the cosmetics, health and beauty and personal care markets.    The newly

The Riverside Company, a global private investor focused on the smaller end of the middle market, has invested in PaleoWest, a Phoenix-based cultural resource management consulting firm. Founded in 2006, PaleoWest is a professional consultancy that assists clients with their need to address federal, state and local level environmental regulations,

Scrona AG, an additive manufacturing startup, has closed a USD9.6 million Series A financing led led by AM Ventures with syndicate partners including TRUMPF Venture, Verve Ventures and Manz GmbH Management Consulting and Investment.